Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
Rajeev Ramakrishna, Terrence Diamond, William Alexander, A. Manoharan, Terry Golombick
Abstract
Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression-free survival without the adverse effects of steroid-based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.
Topics & Concepts
MedicineCurcuminMultiple myelomaRegimenAdverse effectCombination therapyProteasome inhibitorPharmacologyBortezomibSteroidCarfilzomibDrugDexamethasoneInternal medicineOncologyHormoneMultiple Myeloma Research and TreatmentsCurcumin's Biomedical ApplicationsSynthesis and bioactivity of alkaloids